When appropriate, additional services may be recommended to support overall wellness goals
Semaglutide is a single (GLP-1) agonist and tirzepatide is a dual (GIP + GLP-1) agonist, while Retatrutide is a triple agonist adding the glucagon receptor
[Naltrexone] isnt only for people at or approaching rock bottom, says Sunnyside co-founder and CEO Nick Allen
Pantoprazole improves glycemic control in type 2 diabetes: a randomized, double-blind, placebo-controlled trial
In the SURMOUNT-1 trial, tirzepatide produced dose-dependent weight reductions, with average losses approaching or exceeding ~20% at higher doses in adults with obesity who did not have diabetes, numbers that markedly exceed historical pharmacotherapy benchmarks
(Peptide Sciences) Importantly: selective removal of senescent cells without significant impact on non-senescent cells